Century Therapeutics (IPSC) PT Lowered to $5 at Guggenheim
Tweet Send to a Friend
(Updated - March 21, 2025 7:50 AM EDT)
Guggenheim analyst Kelsey Goodwin lowered the price target on Century Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Kelsey Goodwin lowered the price target on Century Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
